Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-13-065873
Filing Date
2013-12-05
Accepted
2013-12-05 17:04:44
Documents
1
Period of Report
2013-12-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v362302_6k.htm 6-K 20578
  Complete submission text file 0001144204-13-065873.txt   21594
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 131260482
SIC: 2834 Pharmaceutical Preparations